Vision
Rose Pharma* is dedicated to improving the lives of irritable bowel syndrome sufferers by developing targeted treatments for pain.
Clinical development
Our lead compound, ROSE-010, is a GLP-1 analogue peptide hormone which controls gastric emptying and transit.